HemaSphere
(Aug 2023)
P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
- Maria Amaya,
- Christine Mcmahon,
- Jonathan Aaron Gutman,
- Marc Schwartz,
- Brett Sevens,
- Connor Sohalski,
- Jennifer Tobin,
- Clayton Smith,
- Craig T Jordan,
- Daniel Aaron Pollyea
Affiliations
- Maria Amaya
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Christine Mcmahon
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Jonathan Aaron Gutman
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Marc Schwartz
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Brett Sevens
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Connor Sohalski
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Jennifer Tobin
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Clayton Smith
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Craig T Jordan
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- Daniel Aaron Pollyea
- 1 University of Colorado Anschutz Medical Campus, Aurora, United States
- DOI
-
https://doi.org/10.1097/01.HS9.0000969068.95778.ba
- Journal volume & issue
-
Vol. 7
p.
e95778ba
WeChat QR code